United States: Healthcare

Subscribe
Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.
Article
Qui Tam Lives To Fight Another Day: What The Eleventh Circuit’s Zafirov Decision Means For The False Claims Act
The False Claims Act’s qui tam provisions are among the federal government’s most important tools for identifying and pursuing alleged fraud involving Medicare, Medicaid, federal health care programs and other government funds. The statute permits a private individual, known as a relator, to bring a False Claims Act action “for the person and for the United States Government” in the name of the government.
United States Healthcare
BI
Buchanan Ingersoll & Rooney PC
Article
FDA Holds Landmark Public Hearing On The Future Therapeutic Use Of Psychedelic Drugs
The FDA, in collaboration with federal partners, held a landmark public hearing on September 14, 2026, to gather input on the future therapeutic use of psychedelic drugs, drawing over 18,000 registered attendees. This hearing represents one of the earliest implementations of Executive Order 14401, which directs federal agencies to expedite research, review, and approval of psychedelic drugs for serious mental health conditions.
United States Healthcare
FH
Foley Hoag LLP
Article
No Surprises Act IDR Portal Overhaul: Key Changes For Providers And Payers
The No Surprises Act's Independent Dispute Resolution process is undergoing a major technology transformation with a new centralized portal for open negotiations. This development introduces standardized procedures for billing disputes between healthcare providers and payers, but also raises critical questions about compliance, system capacity, and whether the portal adequately addresses persistent challenges in payment collection and claim eligibility determination.
United States Healthcare
B
Bracewell
Article
State AG News: Consumer Protection, Healthcare, Voting (September 3-9, 2026)
State attorneys general across the nation are taking decisive action on healthcare access, environmental regulation, consumer protection, and voting rights. From challenging federal restrictions on gender-affirming care to blocking changes in mail voting procedures, these legal battles reveal the growing tension between state authority and federal policy. Will these multistate coalitions succeed in preserving state sovereignty over critical public services?
United States Government
CM
Crowell & Moring LLP
Article
Eli Lilly To Acquire Merida Biosciences
Eli Lilly announces a definitive agreement to acquire Merida Biosciences for up to $2.875 billion in cash, gaining access to an innovative antibody-engineering platform that selectively targets pathogenic autoantibodies in autoimmune and allergic diseases. The acquisition includes Merida's lead program MER511, currently in Phase 1 development for Graves' disease and thyroid eye disease, along with earlier-stage programs addressing food allergy, asthma, and kidney disease.
United States Healthcare
GP
Goodwin Procter LLP
Article
The Tick-ing Time Bomb: Repellents, Regulation, And A Growing Public Health Challenge
Tick-borne diseases are surging across North America and beyond as climate change, ecological shifts, and human behavior converge to expand tick habitats and extend seasonal activity periods. With Lyme disease cases climbing and new tick species establishing themselves in previously unaffected regions, the effectiveness and regulation of insect repellents has become a critical public health concern that varies dramatically across jurisdictions.
Worldwide Government
BC
Bergeson & Campbell
Article
Federal Court Orders Redaction Of Physician-Defendants' Names In Dismissed FCA Qui Tam Action
A federal court in Florida has granted a rare motion to redact physician-defendants' names from all unsealed filings in a dismissed False Claims Act qui tam case, marking a significant departure from the prevailing judicial approach that typically denies such requests. The decision introduces a novel analytical framework distinguishing between the public's interest in understanding case allegations versus knowing the identities of accused parties, particularly where the government declined to intervene afte
United States Litigation
HK
Holland & Knight
Article
The Emerging Federal Overlay On Healthcare Transactions, Amid Expanding State Review Regimes
Federal and state healthcare transparency requirements are rapidly evolving, creating new compliance obligations for private equity sponsors and strategic acquirers in healthcare transactions. As CMS expands ownership disclosure rules and states implement transaction review regimes, deal teams must navigate an increasingly complex regulatory landscape that affects diligence, timing, and closing processes.
United States Finance
D
Dechert
Article
Wellness Program FAQs: Agencies Offer Relief On Retroactive Rewards And Clarify Notice Requirements
The Departments of Labor, Health and Human Services, and Treasury have issued new guidance addressing long-standing questions about health-contingent wellness programs, particularly regarding retroactive rewards and notice requirements. This enforcement relief provides plan administrators with greater flexibility in administering tobacco cessation programs and other wellness incentives...
United States Employment
SS
Seyfarth Shaw LLP
See more